Though lacking any catalytic activity, MLKL has retained its ability to bind nucleotides and it has been found that ATP-binding to MLKL as well as MLKL PsKD mutants, including some identified in cancers (Forbes et al., 2017), stabilized the monomeric OFF state. Here, MLKL is linked to cancer.